Use of locking-loop pigtail nephrostomy catheters in dogs and cats: 20 cases (2004–2009)

Abstract

Placement of locking-loop PNCs was safe, effective, and well tolerated in dogs and cats for temporary urine diversion to achieve renal pelvis decompression.

Uso de glucagon no manejo de obstrução ureteral em um gato com doença renal crônica: relato de caso

“…A fluidoterapia intensa endovenosa ou subcutânea, associada ao uso de diuréticos tem como objetivo estimular a diurese (Kyles et al, 2005;Manassero et al, 2014;Berent et al, 2014). O uso de glucagon tem demonstrado melhorar o débito urinário de gatos em oligúria com obstrução ureteral, mas não foi documentado benefícios a curto e longo prazo para obstrução ureteral (Berent et al, 2012). No presente relato a resposta ao uso deste protocolo mostrou-se satisfatória quando levado em consideração a boa evolução clínica e laboratorial.…”

Interventional Urology

“…In humans, a similar device has been shown to reduce complications associated with externalized nephrostomy tubes and improve quality of life as a longterm treatment modality. 55 The use of a SUB device has been described in abstract form in 25 cats and 2 dogs 10 and has been placed in more than 150 cats to date in the author's practice. The SUB device (Norfolk Vet Products, Skokie, IL) is placed with surgical assistance using fluoroscopic guidance using the modified Seldinger technique (see Fig.…”

Feline ureteral obstructions Part 2: surgical management

“…Intraoperative complications during ureteral stenting include the need for multiple pyelocentesis attempts, need for ureterotomy to facilitate wire or stent passage, ureteral tearing during dilator advancement, stent migration out of the nephrostomy access site, need for papillotomy (up to 40% of cases), ureteral perforation by the guidewire (up to 17% of cases) and urine leakage from the pyelocentesis, ureterotomy or cystotomy incisions ( Berent et al . , Kulendra et al . , Manassero et al .…”

“…When evaluating published survival times from four of the studies, median survival time was 514 to 742 days (range = 2 to 2800 days) ( Berent et al . , Kulendra et al . , Manassero et al .…”